Background: Therapeutic recombinant biological products are essential in modern medicine, but their immunogenicity remains a major concern for both clinical safety and therapeutic efficacy. Protein aggregation may occur during manufacturing, storage, transportation, and administration, potentially increasing immune rec...
An analytical method suite was developed for the bispecific ADC to comprehensively characterize and appropriately control its critical quality attributes, thereby guiding the research, development, and manufacturing process optimization of the ADC product and ensuring its safety, efficacy, and quality consistency.
Xiao-Juan Yu, Le-Le Wang, Wei-Rong Cao et al.· Pharmaceuticals· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.